Hydrocortisone Use During Peri-operation for Pituitary Adenomas
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that withholding hydrocortisone during the peri-operation in
patients with pituitary adenomas whose hypothalamus pituitary adrenal axis are intact are
safe.